Natural treasures from Picrorhiza kurrooa: a computational exploration of drug-like properties and bioactivity of kutkin, cucurbitacin, apocynin and lupanine
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20240026Keywords:
Picrorhiza kurroa, In-silico, Bioinformatics, Pharmacokinetics, ToxicologyAbstract
Background: To analyse and predict the basic pharmacokinetic and toxicological properties of four compounds of interest found in Picrorhiza kurroa (Kutkin, cucurbitacin, apocynin and lupanine) using computational bioinformatics tools.
Methods: The chemical structures and molecular properties of the compounds were obtained from authentic sources and processed for data profiling. 2D structures were converted to 3D structures using ChemSketch software and PHASE module. In silico screening of the 3D structures was performed using bioinformatics prediction software to assess drug-likeness, absorption, blood-brain barrier penetration, enzyme interaction potential, skin penetration, and acute oral toxicity.
Results: Kutkin exhibited poor drug-likeness and low oral absorption, while the other three compounds showed promising drug-like properties and good oral absorption. Cucurbitacin and lupanine were predicted to cross the blood-brain barrier, while Kutkin and Apocynin were not. None of the compounds were substrates for P-glycoprotein, but Kutkin and cucurbitacin were substrates for CYP3A4. All four compounds had low skin penetration. Acute oral toxicity varied, with cucurbitacin classified as highly toxic and the others as slightly toxic.
Conclusions: Cucurbitacin, apocynin, and lupanine have potential for further development as therapeutic agents due to their favorable drug-like properties and good absorption. Kutkin's poor drug-likeness and low absorption make it less suitable for oral drug development. This information provides valuable insights for further research on the medicinal properties of Picrorhiza kurroa and the development of new drugs based on its active compounds.
References
Dutta IC. Non-Timber Forest Products of Nepal: Identification, Classification, Ethnic Uses and Cultivation, Himal doc, HillSide Press, Kathmandu. 2007;44:436-8.
Tiwari T, Chaturvedi P. Efficient in vitro Establishment and Multiplication of Picrorhiza Kurroa Royle Ex Benth through in vitro Raised Seedlings. Res Crop. 2016;17(4):800-807.
Mahajan R, Kapoor N, Singh I. Somatic Embryogenesis and Callus Proliferation in Picrorhiza Kurroa Royle Ex. Benth. J Exp Biol Agric Sci. 2016;4(1):201-9.
Nautiyal BP, Prakash V, Chauhan RS, Purohit H, Nautiyal MC. Assessment of Germinability, Productivity and Cost Benefit Analysis of Picrorhiza Kurrooa Cultivated at Lower Altitudes. Curr Sci. 2001;81:579-85.
Dorsch W, Wagner H. New Antiasthmatic Drugs from Traditional Medicine? Int Arch Allergy Appl Immunol. 1991;94(1-4):262-5.
Bhandari P, Kumar N, Singh B, Ahuja PS. Online HPLC-DPPH Method for Antioxidant Activity of Picrorhiza Kurroa Royle Ex Benth. and Characterization of Kutkoside by Ultra-Performance LC-Electrospray Ionization Quadrupole Time-of-Flight Mass Spectrometry. Indian J Exp Biol. 2010;48(3):323-8.
Bhattacharjee S, Bhattacharya S, Jana S, Bhagel DS. A Review on Medicinally Important Species of Picrorhiza. Int J Pharm Res Biosci. 2013;2:1-16.
Rana CS, Amandeep K, Kimothi GP, Narayan SB, Sastry JLN. Notes on Identity of Picrorhiza-A High Value Threatened Medicinal Plant Group of Western Himalaya. Nelumbo. 2018;60(1):38-43.
Sood H, Chauhan RS. Biosynthesis and Accumulation of a Medicinal Compound, Picroside-I, in Cultures of Picrorhiza Kurroa Royle Ex Benth. Plant Cell Tissue Organ Cult. 2010;100(1):113-7.
Luper S. A Review of Plants Used in the Treatment of Liver Disease: Part Two. Altern Med Rev. 1999;4:178-89.
Sinha S, Bhat J, Joshi M, Sinkar V, Ghaskadbi S. Hepatoprotective Activity of Picrorhiza Kurroa Royle Ex. Benth Extract against Alcohol Cytotoxicity in Mouse Liver Slice Culture. Int J Green Pharm. 2011;5(3):244-53.
Jeyakumar R, Rajesh R, Rajaprabhu D, Ganesan B, Buddhan S, Anandan R. Hepatoprotective Effect of Picrorrhiza Kurroa on Antioxidant Defense System in Antitubercular Drugs-Induced Hepatotoxicity in Rats. Afr J Biotechnol. 2009;8(7):1314-5.
Saraswat B, Visen PK, Patnaik GK, Dhawan BN. Anticholestatic Effect of Picroliv, Active Hepatoprotective Principle of Picrorhiza Kurrooa, against Carbon Tetrachloride Induced Cholestasis. Indian J Exp Biol. 1993;31(4):316-8.
Nipanikar SU, Chitlange SS, Nagore D. Pharmacological Evaluation of Hepatoprotective Activity of AHPL/AYTAB/0613 Tablet in Carbon Tetrachloride-, Ethanol-, and Paracetamol-Induced Hepatotoxicity Models in Wistar Albino Rats. Pharmacogn Res. 2017;9:S41-7.
Chander R, Dwivedi Y, Rastogi R, Sharma SK, Garg NK, Kapoor NK et al. Evaluation of Hepatoprotective Activity of Picroliv (from Picrorhiza Kurroa) in Mastomys Natalensis Infected with Plasmodium Berghei. Indian J Med Res. 1990;92:34-7.
Vaidya AB, Sirsat SM, Doshi JC, Antarkar DS. Selected Medicinal Plants and Formulations as Hepato-Biliary Drugs: An Over-View. Indian J Clin Pharmacol Ther. 1996;14:7-11.
Shitiz K, Pandit S, Chauhan RS, Sood H. Picrosides Content in the Rhizomes of Picrorhiza Kurroa Royle Ex Benth. Traded for Herbal Drugs in the Markets of North India. Int J Med Arom Plants. 2013;3:2249-4340.
Debnath P, Rathore S, Walia S, Kumar M, Devi R, Kumar R. Picrorhiza Kurroa: A Promising Traditional Therapeutic Herb from Higher Altitude of Western Himalayas; Elsevier: Amsterdam. The Netherlands. J Herbal Med. 2020;23:100358.
Fan Y, Cheng M, Cheng Y. The reformation in our organic chemistry classes caused by the excellent software ACD/ chemsketch. J Guangzhou Univ. 2002;6:12-32.
Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluat pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7:42717.
Feixiong C, Weihua L, Yadi Z, Jie S, Zengrui W, Guixia L et al. AdmetSAR: a comprehensive source and free tool for evaluating chemical ADMET properties. J Chem Inf Model. 2012;52(11):3099-105.
Lipinski CA. Lead-and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol. 2004;1(4):337-41.
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Delivery Rev. 2001;46(1-3):3-26.
Jie S, Feixiong C, You X, Weihua L, Yun T. Estimation of ADME Properties with Substructure Pattern Recognition. J Chem Information Modeling. 2010;50(6):1034-41.
Potts RO, Guy RH. Predicting skin permeability. Pharm Res. 1992;9(5):663-9.
